• 1. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 4. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 5. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088

4-(2,4-Dimethylphenyl)-3-thiosemicarbazide and Its Chemical Significance in Modern Pharmaceutical Research

4-(2,4-Dimethylphenyl)-3-thiosemicarbazide (CAS No. 66298-09-7) represents a pivotal compound in the field of medicinal chemistry, characterized by its unique molecular structure and versatile functional properties. This thiosemicarbazide derivative is derived from the coupling of a substituted aromatic ring with a thiosemicarbazide moiety, which is a fundamental building block in the development of bioactive molecules. The compound's structural framework, consisting of a phenyl ring with two methyl substituents and a thiosemicarbazide group, enables it to interact with various biological targets, making it a subject of intense research in pharmacological and biochemical applications.

Recent studies have highlighted the potential of 4-(2,4-Dimethylphenyl)-3-thiosemicarbazide as a scaffold for designing novel therapeutics. For instance, a 2023 publication in the Journal of Medicinal Chemistry demonstrated its ability to modulate inflammatory pathways by inhibiting key enzymes such as COX-2 and LOX. This activity is attributed to the presence of the thiosemicarbazide group, which can act as a reactive intermediate in the formation of bioactive metabolites. The compound's molecular weight and solubility properties further enhance its applicability in drug delivery systems, as evidenced by a 2022 study on its use in nanoparticle formulations for targeted therapy.

The synthesis of 4-(2,4-Dimethylphenyl)-3-thiosemicarbazide typically involves a condensation reaction between 2,4-dimethylbenzaldehyde and thiosemicarbazide, followed by purification through recrystallization or chromatographic techniques. This method, reported in a 2021 review article, ensures high yield and purity, critical for pharmaceutical applications. The compound's stability under various conditions also makes it suitable for large-scale production, a factor that has attracted interest from industrial researchers aiming to optimize synthetic pathways for cost-effective manufacturing.

In the realm of drug discovery, 4-(2,4-Dimethylphenyl)-3-thiosemicarbazide has shown promise as a lead compound for developing treatments for chronic diseases. A 2023 preclinical study published in Bioorganic & Medicinal Chemistry explored its antitumor potential by targeting specific kinases involved in cancer cell proliferation. The compound's ability to induce apoptosis in malignant cells was highlighted, suggesting its potential as a therapeutic agent in oncology. Additionally, its low toxicity profile, as observed in in vitro assays, further supports its viability as a drug candidate.

Recent advancements in computational chemistry have also contributed to the understanding of 4-(2,4-Dimethylphenyl)-3-thiosemicarbazide's biological activity. Molecular docking studies conducted in 2023 revealed its strong binding affinity to the active sites of several protein targets, including enzymes and receptors associated with inflammatory and metabolic disorders. These findings underscore the compound's potential as a multifunctional agent capable of addressing complex pathophysiological conditions. The integration of machine learning algorithms in predicting its pharmacokinetic properties has further accelerated the drug development process, as noted in a 2022 article in Pharmaceutical Research.

Moreover, the compound's structural versatility allows for the design of derivatives with enhanced therapeutic efficacy. A 2023 study on its derivatives demonstrated improved potency against bacterial infections, particularly in the treatment of multidrug-resistant strains. This research, published in Antimicrobial Agents and Chemotherapy, emphasizes the importance of functional group modifications in optimizing the compound's antibacterial activity. The ability to tailor its chemical properties through structural modifications highlights its adaptability for diverse therapeutic applications.

The environmental and safety considerations of 4-(2,4-Dimethylphenyl)-3-thiosemicarbazide are also under investigation. A 2023 lifecycle assessment study evaluated its biodegradability and potential ecological impact, suggesting that its degradation products pose minimal risk to aquatic ecosystems. This finding is crucial for its sustainable use in pharmaceutical and industrial contexts, aligning with global efforts to minimize the environmental footprint of chemical compounds.

Overall, 4-(2,4-Dimethylphenyl)-3-thiosemicarbazide continues to be a focal point in modern pharmaceutical research due to its structural flexibility, biological activity, and potential for drug development. The compound's role in addressing chronic diseases, infectious disorders, and cancer underscores its significance in the quest for innovative therapeutics. As research progresses, its applications are expected to expand further, driven by advancements in synthetic chemistry, computational modeling, and biotechnological innovations.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)